bf/NASDAQ:TOI_icon.jpeg

NASDAQ:TOI

The Oncology Institute of Hope and Innovation

  • Stock

USD

Last Close

3.81

06/11 22:30

Market Cap

34.62M

Beta: 0.88

Volume Today

1.03M

Avg: 176.28K

PE Ratio

−2.13

PFCF: −3.03

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
3.95M
-
-4.02M
201.86%
-14.32M
256.13%
-10.93M
23.70%
1.66M
115.16%
-83.07M
5,113.16%
depreciation and amortization
1.10M
-
2.94M
166.80%
3.18M
8.01%
3.34M
5.14%
4.41M
32.03%
5.87M
33.14%
deferred income tax
688.76K
-
824.76K
19.75%
-1.34M
262.93%
-1.24M
7.57%
183K
114.73%
-76K
141.53%
stock based compensation
94.01K
-
150.80K
60.41%
24.54M
16,170.33%
27.68M
12.83%
17.81M
35.66%
change in working capital
-97.58K
-
3.45M
3,634.49%
991.92K
71.24%
-14.49M
1,560.70%
-20.50M
41.46%
-3.89M
81.01%
accounts receivables
-1.39M
-
-4.33M
212.23%
-6.76M
56.20%
-2.19M
67.54%
-20.29M
824.15%
-4.56M
77.50%
inventory
-296.77K
-
-1.13M
281.67%
-465.24K
58.92%
-1.84M
295.92%
-1.73M
5.97%
-4.38M
153.18%
accounts payables
6.07M
-
5.53M
9.01%
3.76M
32.01%
2.92M
22.40%
-6.19M
312.17%
5.06M
181.74%
other working capital
-4.49M
-
3.38M
175.40%
4.46M
31.85%
-13.37M
399.58%
7.71M
157.66%
3.89M
49.51%
other non cash items
326.93K
-
11.85M
3,525.57%
-33.90M
385.99%
-75.19M
121.82%
27.04M
135.96%
net cash provided by operating activities
5.64M
-
3.62M
35.92%
508.24K
85.94%
-32.68M
6,530.05%
-61.76M
88.97%
-36.31M
41.20%
investments in property plant and equipment
-695.96K
-
-1.20M
73.08%
-1.19M
0.87%
-3.05M
155.17%
-5.53M
81.46%
-4.57M
17.40%
acquisitions net
3.18M
-
-150K
-
-9.11M
5,971.33%
-8.58M
5.82%
-4.46M
48.05%
purchases of investments
-117.51M
-
-9.60M
91.83%
sales maturities of investments
126.08M
-
81.26M
35.55%
other investing activites
-7.50M
-
-126.08M
-
net cash used for investing activites
2.49M
-
-1.20M
148.40%
-8.84M
634.22%
-12.15M
37.42%
-131.61M
982.89%
62.64M
147.59%
debt repayment
-1.81K
-
-312.66K
17,135.78%
-7.25M
2,219.15%
-58K
99.20%
-101K
74.14%
common stock issued
25K
-
-293K
1,272%
20M
6,925.94%
858K
95.71%
126K
85.31%
common stock repurchased
-9M
-
-1.02M
88.68%
dividends paid
-8.20M
-
other financing activites
-25K
-
12.49M
50,071.47%
141.26M
1,030.73%
100.41M
28.92%
-5.85M
105.83%
net cash used provided by financing activities
-8.20M
-
-1.81K
99.98%
11.89M
655,403.80%
154.01M
1,195.59%
92.21M
40.13%
-6.85M
107.43%
effect of forex changes on cash
55.22K
-
net change in cash
-14.69K
-
2.41M
16,503.70%
3.55M
47.43%
109.18M
2,974.23%
-101.16M
192.66%
19.48M
119.25%
cash at beginning of period
52.00K
-
37.32K
28.24%
2.45M
6,455.02%
6.00M
145.20%
115.17M
1,820.21%
14.01M
87.84%
cash at end of period
37.32K
-
2.45M
6,455.02%
6.00M
145.18%
115.17M
1,820.36%
14.01M
87.84%
33.49M
139.03%
operating cash flow
5.64M
-
3.62M
35.92%
508.24K
85.94%
-32.68M
6,530.05%
-61.76M
88.97%
-36.31M
41.20%
capital expenditure
-695.96K
-
-1.20M
73.08%
-1.19M
0.87%
-3.05M
155.17%
-5.53M
81.46%
-4.57M
17.40%
free cash flow
4.95M
-
2.41M
51.26%
-685.88K
128.45%
-35.73M
5,108.91%
-67.28M
88.33%
-40.88M
39.24%

All numbers in USD (except ratios and percentages)